Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: Evidence that MYC is an AR-regulated gene

Carcinogenesis

Volumn 22, Issue 9, 2001, Pages 1521-1526

  Bièche, Ivan ^a,b   Parfait, Béatrice ^a   Tozlu, Sengü L ^b   Lidereau, Rosette ^b   Vidaud, Michel ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b CENTRE RENÉ HUGUENIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ARA70 PROTEIN; ESTROGEN RECEPTOR ALPHA; GENE PRODUCT; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; PROGESTERONE RECEPTOR; TAMOXIFEN; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGE; AGED; ARTICLE; ASSAY; AUTOMATION; BREAST CANCER; BREAST TUMOR; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INVASION; CANCER PATIENT; CANCER SCREENING; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE; MAJOR CLINICAL STUDY; MENOPAUSE; OBSERVATION; ONCOGENE MYC; PREDICTION; PRIORITY JOURNAL; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; VALIDATION PROCESS;

EID: 0034812460     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.9.1521     Document Type: Article

References (27)

1. Improved measurement of androgen receptors in human breast cancer
2. Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer
3. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues
4. Androgen receptors in operable breast cancer: Relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment
5. The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters
6. Androgen receptor mediated growth control of breast cancer and endometrial cancer moduled by antiandrogen- and androgen-like steroids
7. Endocrine therapies of breast cancer
8. Medroxyprogesterone acetate therapy in advanced breast cancer: The predictive value of androgen receptor expression
9. Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor
10. A novel method for real time quantitative RT-PCR
11. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells
12. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies
13. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells
14. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells
15. Nonparametric estimation from incomplete observations
16. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
17. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer
18. Quantitation of myc gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay
19. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications
20. Active allele loss of the androgen receptor gene contributes to loss of androgen receptor expression in female breast cancers
21. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors
22. Multiple androgen response elements and a myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA
23. Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone
24. Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein
25. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability
26. From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
27. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells